Clinical features and survival analysis of very young (Age<35) breast cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5949-5952

  Wei, Xue Qing ^a   Li, Xing ^a   Xin, Xiao Jie ^a   Tong, Zhong Sheng ^a   Zhang, Sheng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Prognosis; Very young patients

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST TUMOR; CANCER GRADING; CANCER STAGING; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; METABOLISM; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PREMENOPAUSE; PROGNOSIS; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER; TUMOR RECURRENCE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREMENOPAUSE; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84890506409     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5949     Document Type: Article

References (21)

1. Ahn SH, Son BH, Kim SW, et al (2007). Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. J Clin Oncol, 25, 2360-8.
2. Bauer KR, Brown M, Cress RD, et al (2007). Descriptive analysis of estrogen receptor(ER)-negative, progesterone receptor(PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a populationbased study from the California cancer Registry. Cancer, 109, 1721-8.
3. Cancello G, Maisonneuve P, Rotmensz N, et al (2010). Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol, 21, 1974-81.
4. Chung M, Chang HR, Bland KI, et al (1996).Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103.
5. Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
6. FitzGerald MG, MacDonald DJ, Krainer M, et al (1996). Germline BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med, 334, 143-9.
7. Gajdos C, Tartter PI, Bleiweiss IJ, et al (2000). Stage 0 to stage _ breast cancer in young women. J Am Coll Surg, 190, 523-9.
8. Goldhirsch A, Glick JH, Gelber RD, et al (1998). Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst, 90, 1601-8.
9. Goldhirsch A, Glick JH, Gelber RD, et al (2001). Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol, 19, 3817-27.
10. Han W, Kim SW, Park IA, et al (2004).Young age: An independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer, 17, 82.
11. Kim JK, Kwak BS, Lee JS, et al (2007). Do very young Korean breast cancer patients have worse outcomes?. Ann Surg Oncol, 14, 3385-91.
12. Kim JK, Kwak BS, Lee JS, et al (2007). Do very young Korean breast cancer patients have worse outcomes?. Ann Surg Oncol, 14, 3385-91.
13. Kothari AS, Beechey-Newman N, D Arrigo C, et al (2002). Breast carcinoma in women age 25 years or less. Cancer, 94, 606-14.
14. Madaras L, Baranyák Z, Kulka J, et al (2013). Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of hungarian patients. Pathol Oncol Res, 19, 723-9.
15. Meng J, Lang RG, Fan Y, Fu L (2007). [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]. Zhonghua Zhong Liu Za Zhi, 29, 284-8. [Article in Chinese]
16. Muscolino G, Villani C, Bedini AV, et al (1987). Young age is not an ominous prognostic factor in breast cancer patients. Tumori, 73, 233-5.
17. Osborne CK, Shou J, Massarweh S, et al (2005). Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res, 11, 865-70.
18. Robson M, Gilewski T, Haas B, et al (1998). BRCA-associated breast cancer in young women. J Clin Oncol, 16, 1642-9.
19. Schmidt RT, Tsangaris TN, Cheek JH (1991). Breast cancer in women under 35 years of age. Am J Surg, 162, 197-201.
20. Vrieling C, Collette L, Fourquet A, et al (2003). Can patienttreatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer, 39, 932-44.
21. Winchester DP(1996).Breast cancer in young women. Surg Clin North Am, 76, 279-87.